Understanding Blood-Based Biomarkers in Alzheimer Disease - Part 1
In part one of this two-part series, Dr. Dan Ackerman and Dr. Trey Bateman discuss current biomarkers for Alzheimer disease and how do you use them in clinic.
Read the full articleYou might also wanna read
The BRidge Towards Implementation of Blood-based Biomarkers to Enable Early and Accurate Diagnosis of Alzheimer's Disease
Conditions : Alzheimer Blood Biomarkers; Alzheimer's Disease (AD) Interventions : Diagnostic Test: Plasma p-tau217 and neurofilament light c
https://doi.org/10.1126/science.aeb6987
Blood biomarker pinpoints when Alzheimer's shift from amyloid to tau occurs—with precision, improving early intervention prospects. PMID:420
IFM | Innovative Diagnostic Tools and Workflows for Suspected Alzheimer's in Primary Care
In this special edition of Inside Family Medicine , sponsored by Roche Diagnostics, h ost Darren Sextro talks with brain health experts Dean
Blood-based test can predict risk of developing symptoms of Alzheimer's up to a decade early
A blood test for the biomarker phosphorylated tau 217 (p-tau217) recently received federal clearance, but questions have emerged about the e
Potential use for blood biomarkers in dementia diagnosis where medical resources are limited
Blood biomarkers are highly accessible for use in diagnosis, and there is very strong potential for them to be valuable in low- and middle-i
Alzheimer’s biomarkers in dental practice: Is innovation outpacing readiness?
Practices should be cautious about adopting complex biomarker tests such as APOE genotyping and blood-based Tau assays. Here's why.
Comments
Sign in to join the conversation.
No comments yet. Be the first.